Feifei Pu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pathology and Forensic Medicine top 10%
- Spine and Intervertebral Disc Pathology
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 6
- Surgery 17
- Management of metastatic bone disease 6
- Co-authors
- Zengwu Shao (17 shared papers)Fengxia Chen (18 shared papers)Zengwu Shao (23 shared papers)Baichuan Wang (14 shared papers)Jianxiang Liu (20 shared papers)Doudou Jing (8 shared papers)Haoyu Guo (5 shared papers)Xin Huang (7 shared papers)
- Journals
- Genes & Diseases (3 papers)OncoTargets and Therapy (3 papers)International Orthopaedics (3 papers)Journal of Controlled Release (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Feifei Pu
67 papers receiving 999 citations
Peers
Comparison fields: 5 of 103
- Cancer Research 234
- Pathology and Forensic Medicine 100
- Molecular Biology 407
- Oncology 110
- Rheumatology 60
Countries citing papers authored by Feifei Pu
This map shows the geographic impact of Feifei Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Pu more than expected).
Fields of papers citing papers by Feifei Pu
This network shows the impact of papers produced by Feifei Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Pu. The network helps show where Feifei Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 146 | |
| 2 | 2017 | 81 | |
| 3 | 2016 | 48 | |
| 4 | 2022 | 48 | |
| 5 | 2021 | 47 | |
| 6 | 2021 | 37 | |
| 7 | 2019 | 30 | |
| 8 | 2014 | 29 | |
| 9 | 2022 | 26 | |
| 10 | 2022 | 26 | |
| 11 | 2017 | 26 | |
| 12 | 2017 | 22 | |
| 13 | 2015 | 21 | |
| 14 | 2019 | 21 | |
| 15 | 2016 | 18 | |
| 16 | 2021 | 17 | |
| 17 | 2016 | 17 | |
| 18 | 2024 | 17 | |
| 19 | 2021 | 16 | |
| 20 | 2018 | 15 |
About Feifei Pu
Feifei Pu is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 73 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers), Management of metastatic bone disease (6 papers), Sarcoma Diagnosis and Treatment (6 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (6 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Cancer Research (234 citations), Pathology and Forensic Medicine (100 citations), Molecular Biology (407 citations), Oncology (110 citations) and Rheumatology (60 citations). Feifei Pu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zengwu Shao, Fengxia Chen, Zengwu Shao, Baichuan Wang, Jianxiang Liu, Doudou Jing, Haoyu Guo, Xin Huang, Zhicai Zhang and Lutong Wang. Their work appears in journals such as Genes & Diseases, OncoTargets and Therapy, International Orthopaedics, Journal of Controlled Release and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.